Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Debt / NOTE 1.250% 9/1
-
Market price (% of par)
-
112.15%
-
Total 13F principal
-
$954,469,022
-
Principal change
-
+$954,464,022
-
Total reported market value
-
$1,105,756,156
-
Number of holders
-
62
-
Value change
-
+$1,105,753,276
-
Number of buys
-
61
Institutional Holders of SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 as of Q3 2023
As of 30 Sep 2023,
SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 was held by
62 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$954,469,022
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, Calamos Advisors LLC, Opti Capital Management, LP, LAZARD ASSET MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, BRAIDWELL LP, Davidson Kempner Capital Management LP, Voya Investment Management LLC, and ADVENT CAPITAL MANAGEMENT /DE/.
This page lists
65
institutional bondholders reporting positions
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.